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Abstract: Three-dimensional (3D) bioprinting technologies have shown great potential in the fabrication of 3D models for
different human tissues. Stem cells are an attractive cell source in tissue engineering as they can be directed by material and
environmental cues to differentiate into multiple cell types for tissue repair and regeneration. In this study, we investigate the
viability of human adipose-derived mesenchymal stem cells (ASCs) in alginate-gelatin (Alg-Gel) hydrogel bioprinted with or
without bioactive glass. Highly angiogenic borate bioactive glass (13-93B3) in 50 wt% is added to polycaprolactone (PCL) to
fabricate scaffolds using a solvent-based extrusion 3D bioprinting technique. The fabricated scaffolds with 12 × 12 × 1 mm3
in overall dimensions are physically characterized, and the glass dissolution from PCL/glass composite over a period of
28 days is studied. Alg-Gel composite hydrogel is used as a bioink to suspend ASCs, and scaffolds are then bioprinted in
different configurations: Bioink only, PCL+bioink, and PCL/glass+bioink, to investigate ASC viability. The results indicate
the feasibility of the solvent-based bioprinting process to fabricate 3D cellularized scaffolds with more than 80% viability on
day 0. The decrease in viability after 7 days due to glass concentration and static culture conditions is discussed. The feasibility
of modifying Alg-Gel with 13-93B3 glass for bioprinting is also investigated, and the results are discussed.
Keywords: Bioprinting; Alginate-gelatin bioink; Borate bioactive glass; Human adipose-derived stem cells
Polymer/bioactive glass composite
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1. Introduction
Bioprinting has been a subject of interest for many
researchers in the past decade, especially as it offers to
create and investigate different tissue models in vitro. In
the tissue engineering and regenerative medicine research
community, bioprinting is referred to as computer-aided
transfer processes for patterning and assembling living
cells and non-living materials with a prescribed twodimensional (2D) or three-dimensional (3D) organization
to produce bio-engineered structures[1]. Although

there is no official categorization of the available
bioprinting techniques, they can be primarily classified
into four categories: (i) Inkjet-based, (ii) extrusionbased, (iii) laser-assisted, and (iv) stereolithographybased. Extrusion-based bioprinting is by far the most
successful and widely adopted technique due to its
compatibility to use of high viscosity materials and a
variety of hydrogels[2-4]. In extrusion-based bioprinting,
melt-extrusion is one of the extensively adopted methods
to fabricate porous support structure for depositing
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bioinks. However, the disadvantage of this method is
that polymers with relatively low melting point such as
polycaprolactone (PCL) are used as a support structure
in a majority of the studies[5]. This method requires high
temperature (~100°C) to extrude even for PCL/glass
composites with 50 wt% glass, making it unsuitable
for bioprinting with the polymer composites. Hence,
in the current work, we use a solvent-based extrusion
bioprinting technique that enables printing with a variety
of polymers as long as they can be dissolved in an organic
solvent to form an extrudable paste[6,7].
In bioprinting, a majority of researchers still use
immortal cell lines to characterize the process viability and
demonstrate the functionality of the bioprinted structures.
However, it is crucial to understand that the cell lines do
not completely mimic primary cells, and the experiments
should be duplicated with primary cells for a comprehensive
conclusion[8]. There is a growing interest in utilizing stem
cells and bioprinting techniques to create 3D cell cultures
for stem cell research[9,10]. Mesenchymal stem cells (MSCs)
have been used for cell therapy and tissue engineering due to
their ability to differentiate into multiple mesenchymal and
non-mesenchymal lineages and their immune modulatory
effects[11]. The density and frequency of MSCs in adipose
tissue are much higher than the more commonly used
source of bone marrow, yielding 100-500 times more cells
per tissue volume[12,13]. Despite having high therapeutic
potential, ability to release angiogenic growth factors, and
self-renewal ability, human adipose-derived mesenchymal
stem cells (ASCs) have not been thoroughly investigated in
bioprinting and 3D cell cultures[9,14].
In bioprinting, coculturing stem cells with tissue-specific
cells and combining stem cells to create a composite bioink
are a common practice to exploit benefits of stem cells in
a bioprinted 3D environment for tissue engineering and
regenerative medicine. For example, MSCs combined
with chondrocytes and bioprinted for cartilage repair and
replacement showed improved proliferative effect and
production of type 2 collagen[15]. Another study reported
that MSCs when combined with primary hepatocytes
supported the long-term culture of hepatocytes in a 3D
environment to aid artificial 3D liver model creation[16].
MSCs were combined with human umbilical vein
endothelial cells to create thick vascularized tissues and
mineralized bone tissues[17,18]. While the incorporation of
growth factors such as the vascular endothelial growth
factor (VEGF) and bone morphogenetic protein is the most
common approach to engineer vascularized bone, very few
researchers have utilized the effect of ionic micronutrients
on bone formation in a 3D environment[19-21].
Bioactive glasses dissolve and release micronutrients
such as calcium, potassium, and sodium to encourage
new tissue growth. Bioactive borate glass (13-93B3) is
different from the traditional silicate-based Bioglass®
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(45S5) as it reacts 10 times faster in comparison to 45S5
glass and even heals “difficult-to-heal” diabetic wounds
without any external growth factors[22,23]. The 13-93B3
glass was approved in 2017 by the Food and Drug
Administration in the United States for treating skin burns
and chronic wounds with a trade name of Mirragen™
Advanced Wound Matrix[24]. The composition of this glass
is provided in Table 1. The release of ions from 13-93B3
glass is thought to be the reason for its wound healing
properties and being highly angiogenic[23,25]. In the current
work, we characterized the bioactivity and 13-93B3 glass
dissolution from PCL matrix and investigated the viability
of ASCs suspended in alginate-gelatin (Alg-Gel) hydrogel
and bioprinted in between PCL/13-93B3 glass filaments.
We also explored the feasibility of direct addition of 1393B3 glass to the Alg-Gel hydrogel as a bioink.

2. Materials and Methods
2.1 PCL and PCL/13-93B3 Pastes Preparation
For PCL paste preparation, 2 g of PCL powder
(MW – 50,000 g/mol, Polysciences, Inc., Warrington, PA,
USA) was added to 2.3 ml chloroform (Sigma-Aldrich, St.
Louis, MO, USA) in a polypropylene tub, which is then
centrifugally mixed for 5 min at 2500 RPM in a FlackTek
SpeedMixer™ (Landrum, SC, USA). To prepare PCL/1393B3 glass composite paste, 1.5 g of 13-93B3 glass
(~20 µm particle size, MO-SCI Corporation, Rolla, MO,
USA) is added to 2.3 ml chloroform and ultrasonicated for
3 min to remove any agglomerates followed by addition
of 1.5 g of PCL powder (to achieve a 50:50 PCL/1393B3 composite). The mixture is centrifugally mixed
for 5 min at 2500 RPM in a SpeedMixer™. The pastes
are transferred to 3 ml syringe barrels (Loctite® Henkel,
Rocky Hill, CT, USA) attached with 25G or 250 µm
internal diameter SmoothFlow Tapered tips (Nordson
EFD, Westlake, OH, USA) before fabrication.

2.2 Cell Culture
Frozen vials of approximately 1 × 106 ASCs obtained
from three separate donors (LaCell, New Orleans, LA) are
thawed, plated on 150 cm2 culture dishes (Nunc, Rochester,
NY) in 25 ml complete culture media (CCM) and incubated
at 37.5°C with 5% humidified CO2. CCM consisted of
10% fetal bovine serum (Corning, Manassas, VA), alpha
minimum essential media (α-MEM, Sigma-Aldrich, St.
Louis, MO), 1% 100 L-glutamine (GE Life Sciences,
Table 1. Compositions (in wt%) of 13‑93B3 glass compared to
45S5 Bioglass®.
Wt. (%)

SiO2

Na2O

K2O

MgO

CaO

P2O5

B2O3

45S5
13‑93B3

45
‑

24.5
6

‑
12

‑
5

24.5
20

6
4

‑
53
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Logan, UT), and 1% ×100× antibiotic/antimycotic (GE Life
Sciences, Logan, UT). After 24 h, the media are removed
and adherent, viable cells are washed twice with phosphatebuffered saline (PBS), harvested with 0.25% trypsin/1 mM
ethylenediaminetetraacetic acid (Gibco) and replated at
100 cells/cm2 in CCM. Media are changed every 3-4 days.
Sub-confluent cells (≤70% confluent) between passage 2
and passage 6 are used for all experiments as subsequent
passages could affect pluripotent properties of ASCs.

layer of bioink extrusion as shown in Figure 1B, which is
done to allow enough shrinkage and swelling of the bioink
in between the polymer-glass composite filaments. A dwell
time of 30 s is used after each layer to allow filament drying
before deposition of subsequent layers. The bioink syringe
is kept in the incubator maintained at ~37.5°C for ~5 min
before bioprinting. The bioprinting process is carried out at
room temperature inside the laminar flow hood following
sterile practices.

2.3 Bioink Preparation

2.5 Scaffold Characterization

0.3 g of Gelatin (Type B, Sigma-Aldrich, St. Louis, MO,
USA) is first dissolved in 10 ml of water (HyClone™
Water, GE Healthcare Life Sciences). The covered glass
beaker is maintained at ~40°C while being magnetically
stirred. On gelatin dissolution, 0.3 g of sodium alginate
(Sigma-Aldrich, St. Louis, MO, USA) is added to the
solution and mixed for at least 6 h to prepare the gelatinalginate hydrogel. 8 × 106 cells are suspended in 200 µL
of CCM and mixed with 4 ml of hydrogel for 5 min in
the beaker using a magnetic stirrer to obtain a uniform
distribution of cells (2 × 106 cells/ml) in the gelatinalginate bioink. The bioink is then transferred to a 3 ml
syringe barrel attached with 22G or 410 µm internal
diameter tips before bioprinting. To prepare a bioink
with the incorporation of glass, 0.06 g of 13-93B3 glass
(10 wt% of hydrogel material) is added to the gelatin
solution and stirred to obtain uniform suspension of glass
particles. Sodium alginate is then added to the solution
and stirred to obtain the Alg-Gel-glass hydrogel. ASCs
suspended in CCM are first hand-mixed in gel and later
magnetically stirred for no more than 5 min to obtain a
uniform distribution of the ASCs in the bioink.

PCL and PCL/13-93B3 scaffolds measuring 10 × 50 × 1 mm3
are fabricated for assessment of mechanical properties.
A sample size of n=10 is used for tensile tests using an Instron
machine (Instron 5969, Norwood, MA, USA). One-way
ANOVA is performed in Minitab and the resulting difference
in means is considered significant if P<0.05. Optical
microscopic images are used to measure the filament width
and pore sizes with at least 10 measurements and the results
are reported as average ± standard deviation. Scaffolds are
dried, weighed, and soaked in Dulbecco’s Modified Eagle
Medium (DMEM) (Gibco) with a weight: volume ratio of
1:200 (g: ml) in high-density polyethylene bottles and kept
in an incubator maintained at 37°C. After soaking for up
to 28 days in DMEM, the scaffolds are dried overnight,
coated with Au-Pd and observed under a scanning electron
microscope (SEM) (S-4700, Hitachi, Japan) to analyze the
surface morphology and formation of hydroxyapatite (HA)like crystals on the surface.

2.4 Scaffold Fabrication
Scaffolds are fabricated using a 3D printer (Geeetech,
Prusa I3 A Pro) modified to have two syringes connected to
external digital syringe dispensers (Loctite®, Rocky Hill, CT,
USA) that are computer controlled. A bioprinter schematic
is shown in Figure 1A, a printing schema is illustrated in
Figure 1B, and the bioprinter set-up inside a laminar flow
hood is shown in Figure 1C. Scaffolds measuring 12 × 12
× 1 mm3 are fabricated with 0-90° filament orientation in
alternate layers. A customized software is written to generate
the G-code and control the printing process. Air pressure of
40 psi is used to extrude the PCL and PCL/13-93B3 pastes
and 4 psi is found to be suitable for the bioink extrusion.
A layer height of 0.1 mm and a printing speed of 10 mm/s are
used to fabricate polymer scaffolds, and a height of 0.2 mm
and a speed of 15 mm/s are used to fabricate bioink scaffolds.
A filament spacing of 0.7 mm is used to fabricate PCL and
PCL/13-93B3 scaffolds for scaffold characterization, and a
spacing of 2.5 mm is used for bioprinting. For bioprinting,
filaments are deposited in 0° direction twice followed by one

2.6 Cell Viability
A live/dead viability kit (ThermoFisher, Carlsbad, CA,
USA) is used to assess the cell viability according to the
manufacturer’s instructions. After 1 day and 7 days, the
scaffolds are washed with PBS and are stained with 1 ml
of prepared reagents (Calcein AM to stain live cells and
Ethidium homodimer-1 to stain dead cells) for 30 min
at room temperature and examined under a confocal
microscope (Nikon A1R-HD Eclipse Ti2, Melville, NY,
USA). Three scaffolds are examined per experimental
group, and images are taken covering an area of 6 × 6 mm2.
Cell viability is calculated as: (live cells/total cells) × 100%.
The maximum intensity projection images are quantified
using ImageJ software and the difference in means is
considered significant if P<0.05 based on the one-way
ANOVA performed in Minitab.

3. Results and Discussion
3.1 Scaffold Fabrication and Physical
Assessment
For scaffolds fabricated without the bioink, PCL/glass
composite scaffolds had a filament width of 328±36 µm
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A

B

C

Figure 1. Solvent-based extrusion bioprinting process: (A) Schematic of the bioprinter, (B) schematic of the printing process, and (C)
bioprinter set-up in a laminar flow hood.

and pore size of 314±22 µm, and the PCL scaffolds
had a filament width and pore size of 340±19 µm and
305±18 µm, respectively. The target was to achieve a
scaffold pore size of ~300 µm, which is a typical pore
size recommended for bone repair and regeneration[26].
With a printer accuracy of ±10 µm, the results are
considered satisfactory for investigating bioactive glass
and its effects on scaffold properties and cell viability
in this study. Figure 2A shows the optical microscopic
images of filaments and pores, and the scaffolds
fabricated for tensile tests. To measure the swelling of
the Alg-Gel hydrogel, fabricated scaffolds measuring
12 × 12 × 0.6 mm3 were cross-linked using 0.3 M CaCl2
for 10 min, washed with PBS, and soaked in DMEM for
24 h. An average area shrinkage of ~30% was observed
in all Alg-Gel scaffolds immediately after cross-linking,
and they swelled by ~12% after 24 h in comparison to
their nominal dimensions. The scaffolds increased in
weight by ~45% after 24 h in comparison to their weight
immediately after cross-linking. Scaffolds fabricated with
Alg-Gel and PCL/glass+Alg-Gel are shown in Figure 2B
along with the tensile testing of the cross-linked Alg-Gel
scaffolds. The ultimate tensile strength, yield strength,

6

and elastic modulus values of the samples are given in
Table 2. Typical stress-strain curves are representing
that the average values are plotted in Figure 2C, where
the curve for Alg-Gel almost overlaps the X-axis. The
results indicate an increase in scaffold brittleness with
the addition of 13-93B3 glass (in 50 wt%). The yield
strength of the PCL/glass composite is higher than the
PCL polymer, and the maximum strength of the polymer
is higher than the composite. Another clear indicator of
brittleness for the PCL/glass is the significant increase
in elastic modulus and its composite behavior in fracture
(Figure 2C).
The mechanical properties of Alg-Gel hydrogel
scaffolds are significantly less in comparison to the
polymer or composite scaffolds. Nevertheless, the values
are in a similar range in terms of tensile strength and
elastic modulus values reported in other studies with
Alg-Gel hydrogels[27,28]. The mechanical properties of
bioprinted PCL+Alg-Gel scaffolds are also significantly
less than PCL or PCL/glass scaffolds fabricated by this
method. This is because the PCL and PCL/glass scaffolds
were completely dried before mechanical tests, whereas
the PCL+Alg-Gel scaffolds did not dry completely

International Journal of Bioprinting (2019)–Volume 5, Issue 2.2
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C

Figure 2. Scaffold fabrication with solvent-based three-dimensional bioprinting: (A) Mechanical testing specimens fabricated with
polycaprolactone (PCL) and PCL/glass with an optical microscopic images showing the filaments and pores, (B) alginate-gelatin (Alg-Gel)
scaffold and PCL/glass+Alg-Gel scaffolds and tensile testing of Alg-Gel scaffolds, (C) typical stress-strain graphs of all samples in this
study.
Table 2. Scaffold’s mechanical properties (in MPa).
Property\sample
Maximum tensile strength
Yield strength
Elastic modulus

PCL: Polycaprolactone, Alg‑Gel: Alginate‑gelatin

PCL

PCL/glass

Alg‑Gel

PCL + Alg‑Gel

6.8 ± 0.9
2.9 ± 0.5
263.9 ± 19.2

4.4 ± 0.4
3.8 ± 0.4
733.9 ± 96.8

0.24 ± 0.1
0.09 ± 0.01
0.3 ± 0.1

1.8 ± 0.3
0.7 ± 0.2
50.6 ± 14.3

during their fabrication as the filaments were surrounded
by wet Alg-Gel and the scaffold was immediately crosslinked by submerging them in CaCl2 solution after
fabrication. Despite this, the PCL+Alg-Gel scaffold
properties show significant improvement in comparison
to the Alg-Gel scaffold as listed in Table 2. Unlike the
melt-deposition process that requires a high temperature
to extrude pastes of polymer-glass composites and thus
making it unfeasible for bioprinting, the solvent-based
extrusion method enables bioprinting with polymer-glass
composites and hydrogels. The solvent-based process
also significantly improves the scaffold properties in
comparison to hydrogel only scaffolds.

3.2 Scaffold Weight Loss and Bioactivity
Our motivation to add 13-93B3 glass to the polymer
matrix in this study is to introduce the bioactive ionic
micronutrients released with 13-93B3 glass dissolution
in the 3D cell culture environment. Previous reports
show that 13-93B3 glass bonds to both hard and soft
tissues, and regenerates good quality tissue in wound

healing applications without forming scar tissue[25,29-31].
These studies have shown that 13-93B3 glass converts to
apatite crystals on the scaffold surface and has a very fast
dissolution rate (between a few hours and days). In the
current study, as glass is dispersed in the highly viscous
polymer-solvent paste, it is important to analyze two
different aspects of the fabrication: (i) The glass particle
distribution in the polymer matrix and (ii) the glass
dissolution over time in the DMEM solution.
To investigate the glass particle distribution in the
paste, a tub of PCL/glass paste was made and transferred
to a syringe and scaffolds measuring 12 × 12 × 0.5 mm3
were fabricated exhausting the entire paste in the syringe.
One tub of paste provided on an average between 13 and
15 scaffolds. The individually labeled scaffolds 1-15
were dried, weighed, and soaked separately in DMEM for
2 weeks to measure the weight loss. The experiment was
repeated 4 times, and the weight loss percentage difference
between scaffolds numbered from 1 to 15 was found to be
not statistically significant (P>0.05). Since a non-uniform
glass particle distribution would provide significant
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differences in scaffold weight loss measurements, the
result of no difference in the percentage scaffold weight
loss from scaffold #1-#15 indirectly proves that the
glass particles are uniformly distributed. Second, to
investigate the glass dissolution, the fabricated PCL/glass
scaffolds were soaked in DMEM and kept in an incubator
maintained at 37°C to simulate the conditions of ASCs in
bioprinted scaffolds. Scaffolds were weighed at different
time intervals to record the weight loss percentages.
The weight loss graphs of PCL and PCL/glass scaffolds
are shown in Figure 3A. The PCL/glass scaffolds show
a maximum weight loss percentage of ~31%, which is
very close to the theoretical weight loss of 32% assuming
the entire 13-93B3 glass in the scaffold either dissolves
or forms HA crystals on the surface. The weight loss
percentage of PCL scaffolds is <3% over a period of
28 days and is in agreement with the reports in literature
which discussed the slow degradation rate of PCL[32]. The
SEM images of the PCL/glass scaffold cross-sections on
day 0 and day 14 are shown in Figure 3B. Some of the
bigger glass particles in the PCL/glass matrix are pointed
with arrows in the figure. The cross-section on day 14
clearly shows higher porosity and fewer glass particles,
indicating the dissolution of a majority of glass particles.
A

The SEM images of the scaffold surface show fine
microcracks (pointed with arrows) on the scaffold surface
on day 0 and the presence of HA-like crystal formations
on the surface on day 14. The X-ray diffraction (XRD)
results in Figure 3C show peaks indicating the formation
of non-stoichiometric HA, which is consistent with the
previous studies where PCL/13-93B3 glass scaffolds
showed similar HA-like conversion but the energydispersive X-ray spectroscopy results also confirmed the
presence of Ca, P, and O elements on the surface[6].

3.3 Cell Viability
For a 3D bioprinting process, it is crucial to determine the
cell viability in a bioink before determining the overall
cell viability when the bioink is extruded with PCL or
PCL/glass material. For this, ASCs viability in the bioink
described in Section 2.3 and their survivability through
the bioprinting process was quantified using the live/
dead assay. The viability was evaluated immediately
after fabrication and cross-linking with 0.3 M CaCl2
solution for 10 min. The bioink only scaffolds provided
cell viability of 81±9%, which is well within the range
of 70-90% reported in other studies with Alg-Gel
hydrogel using different cell types including ASCs at

B

C

Figure 3. (A) Weight loss curves of polycaprolactone (PCL) and PCL/glass scaffolds indicating glass dissolution, (B) scanning electron
microscope images of PCL/glass scaffold showing cross-section and surface morphology immediately after fabrication and after 14 days
in Dulbecco’s Modified Eagle Medium (DMEM); arrows show glass particles in the cross-section and microcracks on the scaffold surface;
scaffolds are shown with hydroxyapatite-like crystal formations on the surface, (C) X-ray diffraction curves of as-received materials,
fabricated scaffolds, and after soaking in DMEM for 14 days; *indicates semi-crystalline peaks of PCL and †indicates unknown peaks.
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different cell concentrations[33-35]. We consider this as the
baseline metric for ASC viability in the Alg-Gel scaffold
fabricated using our process. To investigate the effect of
13-93B3 glass on cell viability, the glass was added in
two different approaches: (i) Indirect – glass is added to
PCL matrix, and bioink filaments are extruded in between
PCL/glass filaments thus making ASCs contact with glass
indirect, and (ii) direct – glass is added to the bioink to
achieve a direct contact between ASCs and glass particles.
ASCs viability was studied in both of the above cases by
performing live/dead assay after 1 day and 7 days.
3.3.1 Indirect Glass Addition
In this approach, as 13-93B3 glass dissolves from the
PCL matrix, the ionic dissolution products that are
physiologically relevant micronutrients for human body
are released to the surrounding Alg-Gel environment
with ASCs. Figure 4 shows the representative maximum
intensity projections of the multiple Live/Dead images
taken at a Z-interval of 40 µm using a confocal
microscope. The green fluorescent spots indicate live
cells and the red fluorescent spots indicate dead cells.
Overall, for all scaffold types, the results indicate more
live cells in comparison to dead cells. Figure 5 shows the
quantification of Live/Dead assay results. A non-uniform
distribution of dead cells along the scaffold thickness was
noticed with a relatively high percentage of dead cells
located in the lower scaffold (LS) region than the rest

of the scaffold (ROS) region. A majority of dead cells in
the images (Figure 4) were observed in the LS region,
which was measured from the scaffold bottom in contact
with the glass Petri dish to 0.1 mm in Z-height. Figure 5B
shows a comparison plot of cell viability in the LS region
to the ROS region.
A relatively high percentage of viable ASCs in the ROS
region in comparison to the LS region for all scaffold
types can be clearly observed in the plot. There could
be two possible explanations for this result: (i) Standoff
distance of the tip during fabrication and (ii) hypoxiclike conditions in the scaffold bottom (LS region). The
standoff distance used to extrude the first layer of bioink
was 0.1 mm for all scaffold types. A small standoff
distance might have caused additional backpressure
on cells in the bioink at the bottom region causing cell
death. To verify this, the bioink was extruded at a larger
standoff distance (1 mm) as a spherical shaped specimen.
Live/dead assay analysis on the specimen indicated no
significant differences in the percentage of dead cells
between the LS and ROS regions. The second possible
reason could be the lack of CCM circulation in the bioink
extruded between PCL and PCL/glass filaments that are
surrounded by relatively dense polymeric filaments in
static culture conditions. Despite being surrounded by
the polymer filaments, ASCs in bioink in the top region
have accessible CCM. One possible solution to avoid low
viability in the LS region that was not considered in this
study could be incubating scaffolds on top of transwell

A

B

C

D

E

F

Figure 4. Live/dead images showing the viability of ASCs in the alginate-gelatin bioink (scale bar: 1 mm). (A, B, C) After 1 day and
(D, E, F) after 7 days incubation, (A, D) bioink, (B, E) polycaprolactone (PCL)+bioink, and (C,F) PCL/glass+bioink. Day 1 images showed
good and viable ASCs with few dead cells in all scaffolds, but cell viability reduced after 7 days of incubation, especially, to ~50% in the
PCL/glass+bioink.
International Journal of Bioprinting (2019)–Volume 5, Issue 2.2
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A

B

Figure 5. Cell quantification using live/dead assay analysis: (A) Cell viability in bioink immediately after cross-linking compared to
viability in scaffolds fabricated in different configurations after 1 day and 7 days in culture and (B) cell viability split up between the lower
scaffold region (0-0.1 mm from the scaffold bottom) and the rest of the scaffold.

inserts where pores could enable CCM circulation to the
LS region.
The results also indicate a reduction in cell viability
in all scaffold types after day 7 and even more
significant reduction in the PCL/glass+bioink scaffold
(P<0.05). The overall decrease in cell viability could
be understood by considering the two different aspects:
(i) The stability of Alg-Gel hydrogel and (ii) the effect
of the environment due to PCL and PCL/glass filaments.
The cell viability in the Alg-Gel hydrogel decreased
from 81% to 64% on day 7, and the reason for reduced
viability in Alg-Gel could be linked to the stability of
the Alg-Gel hydrogel. The composition of hydrogel
used in this study contains both gelatin and alginate in
a 1:1 ratio. The cells are mixed in the hydrogel, and
scaffolds are bioprinted and cross-linked with 0.3M
CaCl2 solution for 10 min, all at room temperature. The
calcium ions crosslink the alginate and it was expected
that the gelatin would be contained in the crosslinked scaffold. However, in the culture conditions at
37°C incubation, gelatin present in the scaffold could
transform into liquid phase and leach out into the media.
To test this, scaffolds without cells were fabricated,
incubated at 37°C in DI water, and the DI water was
tested for the presence of gelatin using proton nuclear
magnetic resonance (1H-NMR) spectroscopy. Figure 6
shows the 1H-NMR spectra of the DI water collected
after 1 day and 7 days of incubation in comparison to the
reference spectra of dissolved gelatin in DI water. The
highlighted region shows typical peaks in the spectra
that correspond to gelatin. It can be clearly observed
that DI water collected after 7 days contains gelatin
while it could be either in insufficient amounts to detect
or not present after 1-day incubation in the absence of
no matching peaks in the 1-day sample. The decrease in
viability could be linked with the gelatin release from the
Alg-Gel hydrogel as studies in the past have indicated
that alginate alone cannot support the mammalian cell
adhesion and proliferation due to the lack of ArginineGlycine-Aspartate (RGD) tripeptide[36,37]. Our future
work will include crosslinking gelatin along with
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Figure 6. Proton nuclear magnetic resonance spectra from sample
DI water (0.6 ml) taken from alginate-gelatin (Alg-Gel) hydrogel
samples incubated in DI water at 37°C with 5% CO2 after 1 day
and 7 days. No gelatin peaks were observed in 1-day sample but
peaks matched with reference gelatin solution (gel) for the 7-day
sample. The additional sharp peaks in Alg-Gel samples refer to
unsuppressed water and ethanol.

alginate to provide a hydrogel that is both cell-friendly
and has sufficient structural integrity.
The second aspect to analyze the decreased cell
viability in all scaffold types after 7 days in culture lies
in the environment change due to simultaneous extrusion
of PCL and PCL/glass filaments along with bioink. In
Figure 5A, it can be clearly observed that the cell viability
in PCL+bioink scaffolds remained identical to that of
bioink scaffolds in the same incubation time indicating
that there is no effect on viability with the extrusion of
PCL filaments. Therefore, it can be concluded that the
solvent-based extrusion process is a viable alternative
method to fabricate cellularized scaffolds with polymer
supporting filaments. It is expected that the viability
of cells in bioink will decide the overall cell viability
in PCL+bioink scaffolds. However, cell viability in
PCL/glass+bioink scaffolds is significantly lower in
comparison to bioink and PCL+bioink scaffolds. The
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Figure 7. Live/dead images showing the viability of human adipose-derived mesenchymal stem cells (ASCs) in spheroid-like samples
(scale bar: 1 mm): (A, B) bioink, (C, D) bioink+glass, (A, C) immediately after crosslinking (day 0), and (B, D) after 7 days (E) ASC
viability on day 0 and day 7. The bioink shows a relatively higher percentage of viable ASCs (green) with increased dead cells (red) after
7 days in culture. Bioink+glass samples on day 0 had more dead cells (viability - 59%) and exhibited high background noise (green) due to
borate ions, which reduced after 7 days in culture (with glass dissolution and media changes).

viability in PCL/glass+bioink scaffolds is decreased
even further due to the 13-93B3 glass effects over and
above the decrease caused due to bioink stability, as
explained earlier. The borate network of 13-93B3 glass is
chemically not as durable as silicate network of Bioglass®
(45S5 glass) and therefore dissolves at a faster rate in
aqueous media. Such faster glass dissolution resulted in
a pH increase of the CCM that could potentially harm
cells in the bioink. As 13-93B3 glass dissolves, the ionic
products are released into the surrounding environment
from the PCL/glass filaments as the scaffold loses almost
16% weight after 7 days (Figure 3A). The weight loss
experiments with PCL/glass scaffolds (without cells) in
static conditions increased the pH up to 8.8 (from a neutral
pH 7-7.4) within one week without the replacement of
DMEM. The bioprinted PCL/glass+bioink scaffolds
were incubated in 5 ml CCM in comparison to 20 ml
DMEM used to soak PCL/glass scaffolds for weight loss
experiments. This resulted in a high ionic concentration
with 13-93B3 glass dissolution in small volumes and
a drastic pH increase that could be the reason for low
cell viability in PCL/glass+bioink scaffolds. Despite
replenishing PCL/glass+bioink scaffolds with new CCM
every 3 days, the pH could still be relatively high near
the locations surrounding PCL/glass filaments due to
insufficient media circulation to bioink surrounded by
PCL/glass filaments in static conditions. In addition, the
concentration of 13-93B3 glass used in the current study
is very high (~45 mg per PCL/glass+bioink scaffold or
~9 mg/ml in concentration) in comparison to other studies
where stem cells are exposed to very low concentrations of
silicate-based glasses ranging from 0.6 to 2.5 mg/ml[38,39].

It was reported that concentrations above 1 mg/ml have
significantly hampered stem cells functions. The results
from our current study also indicate that a faster dissolving
glass such as 13-93B3 (compared to silicate-glasses) and
at high concentrations could damage ASCs rather than
stimulate them and initiate favorable phenotypic changes
with the released ionic micronutrients. Dynamic culture
conditions with a low concentration of 13-93B3 glass
(<2.5 mg/ml) could be more suitable for bioprinting with
PCL/13-93B3 glass composite and will be pursued in the
future.
3.3.2 Direct Glass Addition
The direct mixing of 13-93B3 glass with Alg-Gel
hydrogel and the effect of glass on ASCs were also
investigated. After the addition of 13-93B3 glass to the
gelatin solution, the finer glass particles dissolved rapidly,
causing an increase in the pH (to >8 from 7.4). The release
of Ca2+ and other ions from the glass aided in initiating
the alginate crosslinking in the course of hydrogel
preparation. The viscosity of the Alg-Gel-glass mixture
changed rapidly within 1 h, unlike overnight stirring that
was required for the Alg-Gel solution. After ASCs were
mixed uniformly in the hydrogel, the bioink was extruded
in a 6-well plate at a standoff distance of 5 mm to form
spheroid-like samples (~5 mm in diameter). The samples
were immediately cross-linked, and cell viability was
analyzed using a Live/Dead assay kit. Figure 7 shows
the Live/Dead images of the bioink and bioink+glass
spheroids immediately after cross-linking and after
7 days in culture. The bioink spheroids (Figure 7A) had
a cell viability of 89±3% immediately after crosslinking
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and their viability on day 0 is comparable to bioink
scaffolds fabricated in the indirect glass addition
approach on day 0 (81±9%). The cell viability in bioink
spheroids after 7 days (Figure 7B) decreased significantly
to 73±4% after 7 days in culture (Figure 7E) although
the percentage was relatively higher than the 3D printed
bioink scaffold after 7 days (64±2%). However, it has to
be noted that the cell viability in the ROS region of 3D
printed bioink scaffold (71±4%) was similar to the bioink
spheroids with no statistically significant difference. The
difference in overall viability is due to the low viability
in the bottom layers of the 3D printed scaffold and lack
of media circulation that does not arise in small volume
spheroid culture.
For the bioink+glass spheroids, the results indicated
toxicity with the direct glass addition to Alg-Gel hydrogel
at 6 mg/ml of gel concentration. Figure 7C and D shows
the live/dead images of the bioink+glass spheroidlike specimens on day 0 and after 7 days in culture,
respectively. A high background noise (green) from
glass particles was noticed while imaging bioink+glass
specimens on day 0. A similar green fluorescence
was observed in filaments while culturing cells on
PCL/13-93B3 composite scaffolds[40]. This is due to the
interference of the borate ions from the 13-93B3 glass with
the calcein acetoxymethyl compound present in the live/
dead reagents. ImageJ software was used to remove the
smaller pixels representing the glass particle background
before quantifying the live and dead cells. Bioink+glass
spheroids had low ASC viability of 59±6% on day 0 due
to the pH increase. Despite the initial pH shock and cell
death, the ASC viability improved to 70±5% after 7 days
in a culture which could be due to pH improvement as
the environment becomes closer to neutral pH due to
changing media every 2-3 days. The background noise
observed on day 0 was greatly reduced in samples after
day 7 (Figure 7D), which also indirectly indicates the
glass dissolution and concentration reduction process.
Even as the cell viability is low after 7 days in culture,
there was no significant difference between cell viability
in bioink and bioink+glass spheroids.
The viability of ASCs in 3D cell cultures in the presence
of 13-93B3 glass was investigated in this study. The 1393B3 glass was introduced in two different approaches,
and the overall volumetric glass concentration is
slightly different in the two approaches (9 mg/ml in
indirect approach and 6 mg/ml direct approach). In both
approaches and at such glass concentrations, toxicity
was observed with glass mainly due to pH shock. In a
recent study, Thyparambil et al. investigated the effects
of 13-93B3 glass on phenotypic changes in ASCs in 2D
cell cultures[41]. The experiments were performed in a
similar fashion comparable to those by researchers who
investigated effects of silicate glasses on human stem
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cells which involves loading cells on inserts and adding
glass mixed CCM to the bottom of Petri dish[38,39]. The
results indicated that at concentrations of 2.5 mg/ml for
13-93B3 glass and <1 mg/ml for silicate-based glasses
provide optimum viability, differentiation, and migration
of ASCs. Wang et al. reported the addition of SiO2-CaOP2O5 glass (5 mg/ml of gel) to Alg-Gel hydrogel improved
proliferation and mineralization of osteogenic sarcoma
cells[19]. However, the cell types are different to make a
comparison with our current study. The results from our
study evidently suggest that higher concentrations of
faster degrading 13-93B3 glass rather than the slower
degrading silicate glasses used by other researchers could
have affected the viability of ASCs. A drastic pH change
(pH shock) in addition to static culture conditions further
diminished the viability.
The main outcomes from the current study
are: (i) The proposed solvent-based bioprinting approach
does not affect the viability of cells over and above the
cell viability provided by the bioink as seen in indirect
approach, (ii) viability of ASCs in bioink+glass spheroids
increased after 7 days in culture and even higher than
that of PCL/glass+bioink scaffold after 7 days (indirect
approach), and (iii) viability of ASCs in bioink+glass
spheroids increased whereas viability decreased in bioink
spheroids. These results indicate that direct glass addition
could possibly improve the feasibility of the Alg-Gel
hydrogel as a bioink by aiding in crosslinking and slowing
down gelatin degradation. There are reports that show
crosslinked gelatin with silicate nanoparticles and stabilized
gelatin molecular structure with sodium ions[42,43]. 1393B3 glass and most of the dissolvable bioactive glasses
release sodium ions as they dissolve and this could affect
the Alg-Gel molecular structure. The rheological property
of the Alg-Gel hydrogel with the addition of bioactive
glasses is a current work in progress. We will also utilize
lower concentrations of 13-93B3 glass in our future
work and dynamic culture conditions (or bioreactors) to
control the pH and release of physiologically relevant and
important ionic micronutrients from borate bioactive glass
to stimulate human primary cells in 3D environments
in vitro. The importance of boron ions in vivo is very well
established in wound repair, and so is the importance
of bioactive glasses and their dissolution products in
angiogenesis[44]. The micronutrients released by bioactive
glasses stimulate growth factors such as VEGF and
our current work is an attempt towards establishing the
parameters that are required to create vascularized 3D cell
cultures with human primary cells and bioactive glasses.

4. Conclusions
This study investigated the feasibility of bioprinting
ASCs with highly resorbable, fast reacting, and highly
angiogenic borate bioactive glass (13-93B3) using two
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different approaches. In the first approach, a solventbased extrusion 3D printing technique is used where
PCL/13-93B3 composite (with 50 wt% glass) scaffolds
are fabricated to provide controlled release of glass and
bioactivity in a controlled fashion. Even as PCL/glass +
bioink scaffolds have improved mechanical properties,
the cell viability was decreased due to the high glass
concentration and static culture conditions used in this
study. The PCL + bioink scaffolds provided same cell
viability as bioink scaffolds demonstrating the process
feasibility. Alg-Gel hydrogel was utilized as a bioink
for bioprinting, and it provided a uniform distribution of
ASCs with good cell viability (>80%) immediately after
fabrication which decreased to less than 70% after 7 days
in culture due to unstable molecular structure. In the latter
approach, glass is directly mixed with Alg-Gel hydrogel
to create bioactive bioinks. Results indicated low cell
viability with the direct glass addition due to the initial
pH shock but could be promising in long-term 3D culture
with improved ionic crosslinking of Alg-Gel hydrogel
and cell viability. Overall, the results show the feasibility
of the solvent-based 3D bioprinting technique for tissue
engineering applications and the importance of bioactive
glass concentrations to achieve viable 3D cell cultures.
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